Last update 08 May 2025

Beijing Heyu Pharmaceutical Technology Co., Ltd.

Private Company|2015|Beijing Shi, China

Overview

Tags

Otorhinolaryngologic Diseases
Nervous System Diseases
Cardiovascular Diseases
Recombinant polypeptide
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Recombinant polypeptide1
Top 5 TargetCount
PSD95(Disks large homolog 4)1
GR(Glucocorticoid receptor)1

Related

2
Drugs associated with Beijing Heyu Pharmaceutical Technology Co., Ltd.
HY01
Target
GR
Mechanism
GR agonists
Active Org.
Heyu (Suzhou) Pharmaceutical Technology Co., Ltd.Heyu (Suzhou) Pharmaceutical Technology Co., Ltd.
Originator Org.
Heyu (Suzhou) Pharmaceutical Technology Co., Ltd.Heyu (Suzhou) Pharmaceutical Technology Co., Ltd.
Active Indication
Hearing Loss, Sudden
Inactive Indication
Deafness
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
CN114533874
Patent Mining
Target
PSD95
Mechanism-
Active Org.
Beijing Heyu Pharmaceutical Technology Co., Ltd.
Originator Org.
Beijing Heyu Pharmaceutical Technology Co., Ltd.
Active Indication
Vascular Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Beijing Heyu Pharmaceutical Technology Co., Ltd.
NCT04961099
/ Unknown statusPhase 1
Phase I Clinical Study on the Safety, Tolerance, Efficacy and Pharmacokinetics of Repeated Intratympanic HY01 in Patients With Sudden Sensorineural Hearing Loss
CTR20211258
/ Active, not recruitingPhase 1
突发性聋患者多次鼓室注射HY01的安全性、耐受性、疗效探索和药代动力学特征的I期临床研究
[Translation] A phase I clinical study on the safety, tolerability, efficacy and pharmacokinetic characteristics of multiple intratympanic injections of HY01 in patients with sudden deafness
100 Clinical Results associated with Beijing Heyu Pharmaceutical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Heyu Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Deals associated with Beijing Heyu Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Heyu Pharmaceutical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Phase 1 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
HY01
 ( GR )		Hearing Loss, Sudden
More
Phase 1
CN114533874
 ( PSD95 )		Vascular Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free